Cargando…

Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123234/
https://www.ncbi.nlm.nih.gov/pubmed/35023545
http://dx.doi.org/10.1093/eurheartj/ehab886
_version_ 1784711510624305152
collection PubMed
description
format Online
Article
Text
id pubmed-9123234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91232342022-05-23 Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis Eur Heart J Corrigendum Oxford University Press 2022-01-12 /pmc/articles/PMC9123234/ /pubmed/35023545 http://dx.doi.org/10.1093/eurheartj/ehab886 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Corrigendum
Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title_full Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title_fullStr Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title_full_unstemmed Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title_short Corrigendum to: Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
title_sort corrigendum to: cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the fidelity pooled analysis
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123234/
https://www.ncbi.nlm.nih.gov/pubmed/35023545
http://dx.doi.org/10.1093/eurheartj/ehab886